Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYDG.L Regulatory News (HYDG)

  • There is currently no data for HYDG

Half Year Update

2 Jul 2012 07:00

RNS Number : 5678G
Hydrogen Group PLC
02 July 2012
 



 

 

2 July 2012

Hydrogen Group plc

Half Year Update

Hydrogen Group plc ('Hydrogen' or the 'Group'), the global specialist recruitment business, is today issuing a trading update in respect of the six months ended 30 June 2012 (the 'period').

The Group continued to trade in line with expectations during the period despite the on-going macroeconomic uncertainty, delivering modest growth in Net Fee Income ('NFI') year on year.

Hydrogen continued to progress its strategy of growing a balanced business by carefully selecting and developing its presence in attractive geographies and markets. Group NFI generated from outside the UK increased to approximately 40% during the first six months and, as at the period end, more than 50% of client facing employees were servicing growth markets overseas. The Group renamed its Pharmaceuticals practice to Life Sciences, more accurately reflecting the increased scope of its activity, and together with Oil & Gas resulted in approximately 37% of Group NFI being generated from Technical & Scientific markets. The continued strong performance of these relatively new practices demonstrates Hydrogen's ability to identify new markets as well as its flexibility to deliver quickly on the significant growth opportunities they offer.

Ensuring Hydrogen has the correct infrastructure in place to facilitate long-term growth is a key strategic focus and the Group has continued to make good progress in this area during the period. The Group piloted its new cloud-based global customer relationship management system ("CRM") during the first six months and this will be rolled out across the rest of the business in the second half of the year. The Group also launched the rebrand of its individual UK brands under the Hydrogen brand. Together with the new CRM system this will deliver long-term competitive advantage by enabling Hydrogen to provide a more consistent global service to clients and candidates.

Commenting, Ian Temple, Executive Chairman said:

"Hydrogen has performed well in the first half of the year despite continued uncertainty in the global recruitment markets. We have continued to focus on our strategy of building global practices in our specialist markets and we remain well positioned for the long term.

The business continues to trade in line with our expectations. Nevertheless, on-going debt issues in Europe and the uncertain economic outlook mean that visibility across recruitment markets remains limited. The impact of the Olympic Games on UK recruitment markets in the second half of the year is unknown. However, we are confident in the performance of our international operations and contractor activity, and that the Group remains on target to achieve its 2012 goals."

Enquiries:

Hydrogen Group plc

020 7240 2500

Ian Temple, Executive Chairman

Tim Smeaton, Chief Executive

 

Hudson Sandler

020 7796 4133

Alex Brennan

 

Oriel Securities (NOMAD)

 

020 7710 7600

Nicholas How

Emma Griffin

 

Notes to Editors:

Hydrogen is a specialist recruitment business with a turnover in excess of ÂŁ150m. We build relationships by finding specialist candidates our clients have difficulty sourcing, placing professionals in more than 50 countries.

Our joined-up practice teams combine international reach with local expertise and specialist knowledge, to provide visibility of world class candidates.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIRRSIAFIF
Date   Source Headline
31st Jan 20143:20 pmRNSTotal Voting Rights
21st Jan 20147:00 amRNSYear End Trading Update and Notice of Results
8th Jan 20147:00 amRNSBlocklisting Interim Review
8th Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 20147:00 amRNSTotal Voting Rights
17th Dec 20137:00 amRNSTrading Statement
2nd Dec 20137:00 amRNSTotal Voting Rights
1st Nov 20137:00 amRNSTotal Voting Rights
22nd Oct 20133:57 pmRNSHolding(s) in Company
21st Oct 20133:33 pmRNSHolding(s) in Company
1st Oct 20137:00 amRNSTotal Voting Rights
12th Sep 20139:59 amRNSHolding(s) in Company
9th Sep 20137:00 amRNSInterim Results Statement
2nd Sep 20138:00 amRNSTotal Voting Rights
2nd Sep 20137:00 amRNSChange of Registered Office
21st Aug 20139:45 amRNSHolding(s) in Company
1st Aug 20139:51 amRNSTotal Voting Rights
9th Jul 20137:00 amRNSTrading Update
8th Jul 20133:01 pmRNSBlocklisting Interim Review
8th Jul 20132:58 pmRNSBlocklisting Interim Review
1st Jul 20138:18 amRNSTotal Voting Rights
28th Jun 20137:00 amRNSChange of Adviser
5th Jun 20133:19 pmRNSDirector/PDMR Shareholding
31st May 20135:01 pmRNSTotal Voting Rights
21st May 201311:16 amRNSResult of AGM
14th May 201310:32 amRNSBlocklisting application
30th Apr 20134:53 pmRNSHolding(s) in Company
30th Apr 20134:45 pmRNSTotal Voting Rights
8th Apr 201312:18 pmRNSAnnual Report and Accounts and Notice of AGM
28th Mar 201310:19 amRNSTotal Voting Rights
27th Mar 201311:13 amRNSHolding(s) in Company
27th Mar 201311:09 amRNSDirector/PDMR Shareholding
21st Mar 20132:03 pmRNSDirector/PDMR Shareholding
15th Mar 201310:51 amRNSAdditional Listing
11th Mar 20137:00 amRNSFinal Results
18th Feb 20137:00 amRNSNotice of Results
8th Feb 201311:00 amRNSGrant of options to directors
31st Jan 20135:07 pmRNSTotal Voting Rights
14th Jan 20137:00 amRNSPre-Close Trading Update
8th Jan 201310:55 amRNSNotice of Pre-close Trading Update
8th Jan 20137:00 amRNSBlocklisting Interim Review
15th Nov 20127:00 amRNSTrading Update
8th Oct 20124:24 pmRNSDirector/PDMR Shareholding
18th Sep 201210:18 amRNSEBT Dealings
10th Sep 201210:46 amRNSCorrection - Changes to the Board of Directors
10th Sep 20127:00 amRNSChanges to the Board of Directors
10th Sep 20127:00 amRNSInterim Results Statement
31st Aug 20127:00 amRNSTotal Voting Rights
14th Aug 20122:18 pmRNSNotice of Interim Results
31st Jul 20123:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.